{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T09:24:50Z","timestamp":1789809890837,"version":"4.0.1"},"reference-count":48,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology\/Oncology Clinics of North America"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.hoc.2017.08.007","type":"journal-article","created":{"date-parts":[[2017,10,26]],"date-time":"2017-10-26T12:22:50Z","timestamp":1509020570000},"page":"1029-1044","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Myeloproliferative Disorders"],"prefix":"10.1016","volume":"31","author":[{"given":"Brian","family":"Meier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John H.","family":"Burton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.hoc.2017.08.007_bib1","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1182\/blood-2002-04-1199","article-title":"The World Health Organization (WHO) classification of the myeloid neoplasms","volume":"100","author":"Vardiman","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2017.08.007_bib2","series-title":"Harrison\u2019s principles of internal medicine","first-page":"898","article-title":"Polycythemiavera and other myeloproliferative diseases","author":"Spivak","year":"2012"},{"issue":"4","key":"10.1016\/j.hoc.2017.08.007_bib3","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ccr.2005.03.023","article-title":"Activating mutation in the tyrosine kinase JAK2 in polycythemiavera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis","volume":"7","author":"Levine","year":"2005","journal-title":"Cancer Cell"},{"issue":"4","key":"10.1016\/j.hoc.2017.08.007_bib4","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1182\/blood.V6.4.372.372","article-title":"Some speculations on the myeloproliferative syndromes","volume":"6","author":"Dameshek","year":"1951","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2017.08.007_bib5","series-title":"Harrison\u2019s principles of internal medicine","first-page":"887","article-title":"Aplastic anemia, myelodysplasia, and related bone marrow failure syndromes","author":"Young","year":"2012"},{"key":"10.1016\/j.hoc.2017.08.007_bib6","series-title":"Williams hematology","first-page":"231","article-title":"Hematopoietic stem cells, progenitors, and cytokines","author":"Kaushansky","year":"2010"},{"issue":"6774","key":"10.1016\/j.hoc.2017.08.007_bib7","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/35004599","article-title":"A\u00a0clonogenic common myeloid progenitor that gives rise to all myeloid lineages","volume":"404","author":"Akashi","year":"2000","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.hoc.2017.08.007_bib8","first-page":"165","article-title":"Hematopoietic growth factors","volume":"46","author":"Bociek","year":"1996","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"10.1016\/j.hoc.2017.08.007_bib9","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1172\/JCI113363","article-title":"Peritubular cells are the site of erythropoietin synthesis in the murine hypoxic kidney","volume":"81","author":"Lacombe","year":"1988","journal-title":"J\u00a0Clin Invest"},{"issue":"3","key":"10.1016\/j.hoc.2017.08.007_bib10","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1172\/JCI118210","article-title":"Thrombopoietin expands erythroid progenitors, increases red cell production, and enhances erythroid recovery after myelosuppressive therapy","volume":"96","author":"Kaushansky","year":"1995","journal-title":"J\u00a0Clin Invest"},{"issue":"23","key":"10.1016\/j.hoc.2017.08.007_bib11","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1056\/NEJMra063728","article-title":"The myeloproliferative disorders","volume":"355","author":"Campbell","year":"2006","journal-title":"N\u00a0Engl J Med"},{"issue":"5405","key":"10.1016\/j.hoc.2017.08.007_bib12","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/243290a0","article-title":"A\u00a0new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining","volume":"243","author":"Rowley","year":"1973","journal-title":"Nature"},{"issue":"1497","key":"10.1016\/j.hoc.2017.08.007_bib13","first-page":"19","article-title":"A\u00a0minute chromosome in human chronic granulocytic leukemia","volume":"132","author":"Nowell","year":"1960","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.hoc.2017.08.007_bib14","first-page":"1035","article-title":"Discordant maturation as the primary biological defect in chronic myelogenous leukemia","volume":"48","author":"Strife","year":"1988","journal-title":"Cancer Res"},{"issue":"8","key":"10.1016\/j.hoc.2017.08.007_bib15","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1182\/blood.V83.8.2038.2038","article-title":"Inhibition of apoptosis by BCR-ABL in chronic myeloid leukemia","volume":"83","author":"Bedi","year":"1994","journal-title":"Blood"},{"issue":"56","key":"10.1016\/j.hoc.2017.08.007_bib16","doi-asserted-by":"crossref","first-page":"8605","DOI":"10.1038\/sj.onc.1206088","article-title":"Mechanisms underlying abnormal trafficking and expansion of malignant progenitors in CML: BCR\/ABL-induced defects in integrin function in CML","volume":"21","author":"Salesse","year":"2009","journal-title":"Oncogene"},{"key":"10.1016\/j.hoc.2017.08.007_bib17","series-title":"Williams hematology","first-page":"1223","article-title":"Polycythemiavera","author":"Prchal","year":"2010"},{"issue":"1","key":"10.1016\/j.hoc.2017.08.007_bib18","first-page":"11","article-title":"Cancer statistics, 2013","volume":"63","author":"Siegel","year":"2013","journal-title":"CA Cancer J Clin"},{"issue":"9","key":"10.1016\/j.hoc.2017.08.007_bib19","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1038\/leu.2013.163","article-title":"Survival and prognosis among 1545 patients with contemporary polycythemiavera: an international study","volume":"27","author":"Tefferi","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.hoc.2017.08.007_bib20","unstructured":"Kremyanskaya M, Najfeld V, Mascarenhas J, et\u00a0al. The polycythemias. In: Hoffman R, Benz EJ Jr, Silberstein L, et\u00a0al, editors. Hematology: basic principles and practice. Philadelphia: Saunders-Elsevier; 2013. p. 998."},{"issue":"5","key":"10.1016\/j.hoc.2017.08.007_bib21","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/bjh.12290","article-title":"Delayed choroidal and retinal blood flow in polycythaemia vera patients with transient ocular blindness: a preliminary study with fluorescein angiography","volume":"161","author":"Yang","year":"2013","journal-title":"Br J Haematol"},{"key":"10.1016\/j.hoc.2017.08.007_bib22","series-title":"Williams hematology","first-page":"1237","article-title":"Essential thrombocythemia","author":"Beer","year":"2010"},{"issue":"2","key":"10.1016\/j.hoc.2017.08.007_bib23","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1365-2141.2005.05764.x","article-title":"JAK2 mutation in essential thrombocythaemia: clinical associations and long-term prognostic relevance","volume":"131","author":"Wolanskyj","year":"2005","journal-title":"Br J Haematol"},{"issue":"12","key":"10.1016\/j.hoc.2017.08.007_bib24","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1056\/NEJMra035363","article-title":"Thrombocytosis","volume":"350","author":"Schafer","year":"2004","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.hoc.2017.08.007_bib25","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1056\/NEJM199907153410306","article-title":"The biology of chronic myeloid leukemia","volume":"341","author":"Faderl","year":"1999","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.hoc.2017.08.007_bib26","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1046\/j.1365-2141.1997.d01-1982.x","article-title":"Clinical features at diagnosis in 430 patients with chronic myeloid leukaemia seen at a referral centre over a 16-year period","volume":"96","author":"Savage","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1016\/j.hoc.2017.08.007_bib27","series-title":"Williams hematology","first-page":"1331","article-title":"Chronic myelogenous leukemia and related disorders","author":"Liesveld","year":"2010"},{"key":"10.1016\/j.hoc.2017.08.007_bib28","series-title":"Williams hematology","first-page":"129","article-title":"Primary myelofibrosis","author":"Lichtman","year":"2010"},{"issue":"13","key":"10.1016\/j.hoc.2017.08.007_bib29","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1182\/blood-2008-07-170449","article-title":"New prognostic scoring system for\u00a0primary myelofibrosis based on a study of the international working group for myelofibrosis research and treatment","volume":"113","author":"Cervantes","year":"2009","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.hoc.2017.08.007_bib30","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1182\/blood-2009-08-238956","article-title":"Thrombosis in primary myelofibrosis: incidence and risk factors","volume":"115","author":"Barbui","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2017.08.007_bib31","series-title":"Harrison\u2019s principles of internal medicine","first-page":"905","article-title":"Acute and chronic myeloid leukemia","author":"Wetzler","year":"2012"},{"issue":"1","key":"10.1016\/j.hoc.2017.08.007_bib32","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1600-0609.1977.tb01474.x","article-title":"The peripheral blood in chronic granulocytic leukaemia. Study of 50 untreated Philadelphia-positive cases","volume":"18","author":"Spiers","year":"1977","journal-title":"Scand J Haematol"},{"issue":"10","key":"10.1016\/j.hoc.2017.08.007_bib33","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1002\/1097-0142(19810515)47:10<2470::AID-CNCR2820471026>3.0.CO;2-0","article-title":"Prognostic features at diagnosis of chronic myelocytic leukemia","volume":"47","author":"Gomez","year":"1981","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.hoc.2017.08.007_bib34","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.mayocp.2011.11.001","article-title":"One thousand patients with primary myelofibrosis: the Mayo Clinic experience","volume":"87","author":"Tefferi","year":"2012","journal-title":"Mayo Clin Proc"},{"issue":"2","key":"10.1016\/j.hoc.2017.08.007_bib35","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1001\/archinte.1982.003401500410010","article-title":"The use of cimetidine for the treatment of pruritus in polycythemiavera","volume":"142","author":"Weick","year":"1982","journal-title":"Arch Intern Med"},{"issue":"7","key":"10.1016\/j.hoc.2017.08.007_bib36","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1182\/blood.V99.7.2627","article-title":"Selective serotonin reuptake inhibitors are effective in the treatment of polycythemiavera\u2013associated pruritus","volume":"99","author":"Tefferi","year":"2002","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.hoc.2017.08.007_bib37","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1200\/JCO.2005.07.062","article-title":"Vascular and neoplastic risk in a large cohort of patients with polycythemiavera","volume":"23","author":"Marchioli","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"issue":"8102","key":"10.1016\/j.hoc.2017.08.007_bib38","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/S0140-6736(78)92098-6","article-title":"Vascular occlusive episodes and venous haematocrit in primary proliferative polycythaemia","volume":"312","author":"Pearson","year":"1978","journal-title":"Lancet"},{"key":"10.1016\/j.hoc.2017.08.007_bib39","first-page":"107","article-title":"Polycythemia vera and acute coronary syndromes: pathogenesis, risk factors and treatment","volume":"1","author":"Adel","year":"2013","journal-title":"J\u00a0Hematol Thromb Dis"},{"issue":"2","key":"10.1016\/j.hoc.2017.08.007_bib40","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1182\/blood-2007-07-102665","article-title":"Postsurgery outcomes in patients with polycythemia vera and essential thrombocythemia: a retrospective survey","volume":"111","author":"Ruggeri","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2017.08.007_bib41","unstructured":"Ugras-Rey S. Selected hematologic emergencies. In: Marx J, editor. Rosen\u2019s emergency medicine: concepts and clinical practice. Chapter 12. 8th edition. St Louis (MO): Mosby-Year Book, Inc; 2014. p. 1617\u201328.e1."},{"key":"10.1016\/j.hoc.2017.08.007_bib42","unstructured":"Janz T, Hamilton G. Anemia, polycythemia, and white blood cell disorders. In: Marx J, editor. Rosen\u2019s emergency medicine: concepts and clinical practice. Chapter 121. 8th edition. St Louis (MO): Mosby-Year Book, Inc; 2014. p. 1586\u2013605.e2."},{"issue":"3","key":"10.1016\/j.hoc.2017.08.007_bib43","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/j.1365-2141.2007.06674.x","article-title":"Leucocytosis in polycythaemia vera predicts both inferior survival and leukaemic transformation","volume":"138","author":"Gangat","year":"2007","journal-title":"Br J Haematol"},{"issue":"26","key":"10.1016\/j.hoc.2017.08.007_bib44","doi-asserted-by":"crossref","first-page":"5128","DOI":"10.1182\/blood-2012-07-444067","article-title":"Development and validation of an international prognostic score of thrombosis in World Health Organization\u2013essential thrombocythemia (IPSET-thrombosis)","volume":"120","author":"Barbui","year":"2012","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.hoc.2017.08.007_bib45","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1182\/blood-2012-07-443770","article-title":"Anagrelide compared with hydroxyurea in WHO-classified essential thrombocythemia: the ANAHYDRET study, a randomized controlled trial","volume":"121","author":"Gisslinger","year":"2013","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.hoc.2017.08.007_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0002-9343(90)90119-X","article-title":"Proposal for a simple synthesis prognostic staging system in chronic myelogenous leukemia","volume":"88","author":"Kantarjian","year":"1990","journal-title":"Am J Med"},{"issue":"7","key":"10.1016\/j.hoc.2017.08.007_bib47","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1182\/blood-2012-03-378919","article-title":"How I treat newly diagnosed chronic phase CML","volume":"120","author":"Cortes","year":"2012","journal-title":"Blood"},{"issue":"1\u20132","key":"10.1016\/j.hoc.2017.08.007_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/10428190009053534","article-title":"Hyperleukocytic leukemias and leukostasis: a review of pathophysiology, clinical presentation and management","volume":"39","author":"Porcu","year":"2000","journal-title":"Leuk Lymphoma"}],"container-title":["Hematology\/Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858817301314?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858817301314?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:04:45Z","timestamp":1760184285000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889858817301314"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":48,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S0889858817301314"],"URL":"https:\/\/doi.org\/10.1016\/j.hoc.2017.08.007","relation":{},"ISSN":["0889-8588"],"issn-type":[{"value":"0889-8588","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Myeloproliferative Disorders","name":"articletitle","label":"Article Title"},{"value":"Hematology\/Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hoc.2017.08.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}